AzTrials
AzTrials

HypohydratedNCT04140045

The Effect of Manipulating Hydration Status During Cycling in the Heat on Acute Kidney Injury Biomarkers

A study testing Water intake in people with Hypohydrated and Euhydrated, run by Loughborough University at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Acute Kidney Injury (AKI) is common in prolonged endurance events. Risk factors for exercise-associated AKI include: the exercise itself, heat, hypohydration, muscle breakdown and non-steroidal anti-inflammatory drug (NSAID) use. Read more about this study

Who is it for?
Ages 18 to 50 years, men onlyHealthy volunteers can take part
Conditions the study is for
Hypohydrated, Euhydrated
What is being tested?
Water intake
Could I receive a placebo?
No, everyone receives an active treatment
How many people
14 participants
Where
1 siteUnited Kingdom
Study dates
28 Oct 2019to 17 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy
  • recreationally active

Who cannot join

  • Smoker/vaper
  • regular use of anti-inflammatory medications (e.g. ibuprofen)
  • history of kidney disease or diabetes

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Loughborough University

    Loughborough, LE11 3TU

Other trials in United Kingdom

About this study

Official title: The Effect of Hypohydration During Cycling in the Heat on Acute Kidney Injury Biomarkers

Acute Kidney Injury (AKI) is common in prolonged endurance events. Risk factors for exercise-associated AKI include: the exercise itself, heat, hypohydration, muscle breakdown and non-steroidal anti-inflammatory drug (NSAID) use. Prior research from our laboratory showed the hypohydration during high-intensity running increased a biomarker of AKI (urine osmolality-corrected kidney injury molecule 1). Therefore, the current study will now investigate the effect of manipulating hydration status during cycling on biomarkers of AKI.

Being tested
Water intake

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Water intakeOther

    Water intake will be manipulated in both arms to create a hypohydrated state and a euhydrated state, post-exercise

Study groups in NCT04140045
Study groupRoleWhat they receive
HypohydratedExperimentalParticipants will be required to restrict their water intake during cycling in the heat (90-120 minutes at 35°C), in order to achieve a body mass loss of approximately 3%.
Receives: Other: Water intake
EuhydratedExperimentalParticipants will be provided with water intake that matches their sweat losses during cycling in the heat (90-120 minutes at 35°C)
Receives: Other: Water intake

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in urinary Kidney Injury Molecule 1 (uKIM-1) (uncorrected/raw values and urine osmolality-corrected values)

    A novel protein biomarker for acute kidney injury

    Measured: Pre-exercise (baseline), post-exercise (immediately after the intervention), 24 hours post-baseline

  2. Changes in urinary neutrophil gelatinase-associated lipocalin (uNGAL) (uncorrected/raw values and urine osmolality-corrected values)

    A novel protein biomarker for acute kidney injury

    Measured: Pre-exercise (baseline), post-exercise (immediately after the intervention), 24 hours post-baseline

  3. Changes in urine osmolality

    A measure of urine concentration.

    Measured: Pre-exercise (baseline) and post-exercise (immediately after the intervention), as well as all urine produced from post-exercise until 24 hours post-baseline

  4. Changes in serum creatinine

    Serum creatinine is a marker of kidney function

    Measured: Pre-exercise (baseline), post-exercise (immediately post-exercise), 24 hours post-baseline

  5. Incidence of Acute Kidney Injury (as determined by changes in serum creatinine)

    A rise in serum creatinine of 1.5 fold or more from baseline will be defined as acute kidney injury

    Measured: Pre-exercise (baseline), post-exercise (immediately post-exercise), 24 hours post-baseline

Secondary outcomes (19)
  1. Plasma volume changes

    Measured: Pre-exercise (baseline), post-exercise (immediately after the intervention), 24 hours post-baseline

  2. Changes in serum osmolality

    The gold standard marker of hydration status

    Measured: Pre-exercise (baseline), post-exercise (immediately after the intervention), 24 hours post-baseline

  3. Body mass changes

    Measured: pre-exercise (baseline), throughout exercise, post-exercise (immediately after the intervention), 24 hours post-baseline

  4. Changes in creatine kinase

    A marker of muscle damage

    Measured: Pre-exercise (baseline), post-exercise (immediately after the intervention), 24 hours post-baseline

  5. Changes in lactate dehydrogenase

    A marker of muscle damage

    Measured: Pre-exercise (baseline), post-exercise (immediately after the intervention), 24 hours post-baseline

  6. Ad libitum energy (Kj), carbohydrate (g), sugar (g), protein (g), fat (g), saturated fat (g), sodium (g) and water intake (g).

    Participants will complete a weighed food and fluid diary, using a set of food scales and a diary, to record all food and fluid that they ingest. This data will then be analysed using dietary analysis software (e.g. Nutritics)

    Measured: from post-exercise (immediately after the intervention) until 24 hours post-baseline

  7. Changes in headache scores

    Participants will be asked to rate their headache on a scale of 0-10, with higher scores meaning a worse outcome .

    Measured: pre-exercise (baseline), every 30 minutes during exercise (30, 60,90 and 120 minutes), post-exercise (immediately after the intervention) and 24 hours post-baseline

  8. Changes in nausea scores

    Participants will be asked to rate their nausea on a scale of 0-10, with higher scores meaning a worse outcome .

    Measured: pre-exercise (baseline), every 30 minutes during exercise (30, 60,90 and 120 minutes), post-exercise (immediately after the intervention) and 24 hours post-baseline

  9. Changes in dizziness scores

    Participants will be asked to rate their dizziness on a scale of 0-10, with higher scores meaning a worse outcome .

    Measured: pre-exercise (baseline), every 30 minutes during exercise (30, 60,90 and 120 minutes), post-exercise (immediately after the intervention) and 24 hours post-baseline

  10. Changes in thirst scores

    Participants will be asked to rate their thirst on a scale of 0-10, with higher scores meaning a worse outcome .

    Measured: pre-exercise (baseline), every 30 minutes during exercise (30, 60,90 and 120 minutes), post-exercise (immediately after the intervention) and 24 hours post-baseline

  11. Changes in thermal comfort scores

    Participants will be asked to rate their thermal comfort on a scale of -10 to 10, with -10 being cold impossible to bear and 10 being heat impossible to bear

    Measured: pre-exercise (baseline), every 30 minutes during exercise (30, 60,90 and 120 minutes), post-exercise (immediately after the intervention) and 24 hours post-baseline

  12. Changes in gastrointestinal comfort scores

    Participants will be asked to rate their gastrointestinal comfort on a scale of 0-10, with higher scores meaning a worse outcome .

    Measured: pre-exercise (baseline), every 30 minutes during exercise (30, 60,90 and 120 minutes), post-exercise (immediately after the intervention) and 24 hours post-baseline

  13. Changes in stomach fullness scores

    Participants will be asked to rate their stomach fullness on a scale of 0-10, with higher scores meaning a worse outcome .

    Measured: pre-exercise (baseline), every 30 minutes during exercise (30, 60,90 and 120 minutes), post-exercise (immediately after the intervention) and 24 hours post-baseline

  14. Changes in stomach bloatedness scores

    Participants will be asked to rate their stomach bloatedness on a scale of 0-10, with higher scores meaning a worse outcome .

    Measured: pre-exercise (baseline), every 30 minutes during exercise (30, 60,90 and 120 minutes), post-exercise (immediately after the intervention) and 24 hours post-baseline

  15. Changes in urge to vomit scores

    Participants will be asked to rate their urge to vomit on a scale of 0-10, with higher scores meaning a worse outcome .

    Measured: pre-exercise (baseline), every 30 minutes during exercise (30, 60,90 and 120 minutes), post-exercise (immediately after the intervention) and 24 hours post-baseline

  16. Changes in urinary creatinine

    Measured: pre-exercise (baseline), post-exercise (immediately after the intervention) and 24 hours post-baseline

  17. Changes in heart rate

    Provides insight into exercise intensity

    Measured: Will be monitored throughout the exercise intervention, at 15 minute intervals (15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes, 105 minutes and 120 minutes)

  18. changes in rating of perceived exertion

    Provides insight into exercise intensity

    Measured: Will be monitored throughout the exercise intervention, at 30 minute intervals (30 minutes, 60 minutes, 90 minutes and 120 minutes)

  19. Changes in aural temperature

    in-ear temperature

    Measured: Will be determined immediately prior to the exercise intervention (at rest) and then throughout the exercise intervention at 15 minute intervals (15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes, 105 minutes and 120 minutes)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Oct 2019
  2. Study start28 Oct 2019
  3. Primary completion17 Mar 2020
  4. Study completion17 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
14 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04140045
Sponsor's protocol ID
R19-P130
Status last verified
Jul 2020
First submitted
21 Oct 2019
Last updated
3 Aug 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Water intake in people with Hypohydrated and Euhydrated, run by Loughborough University at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in urinary Kidney Injury Molecule 1 (uKIM-1) (uncorrected/raw values and urine osmolality-corrected values) (time frame: Pre-exercise (baseline), post-exercise (immediately after the intervention), 24 hours post-baseline). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in